201 related articles for article (PubMed ID: 26122770)
1. Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines.
Temburnikar KW; Ross CR; Wilson GM; Balzarini J; Cawrse BM; Seley-Radtke KL
Bioorg Med Chem; 2015 Aug; 23(15):4354-4363. PubMed ID: 26122770
[TBL] [Abstract][Full Text] [Related]
2. Mitotic arrest of breast cancer MDA-MB-231 cells by a halogenated thieno[3,2-d]pyrimidine.
Ross CR; Temburnikar KW; Wilson GM; Seley-Radtke KL
Bioorg Med Chem Lett; 2015 Apr; 25(8):1715-1717. PubMed ID: 25791452
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Properties of Halogenated Pyrrolo[3,2-d]pyrimidines with Decreased Toxicity via N5 Substitution.
Cawrse BM; Lapidus RS; Cooper B; Choi EY; Seley-Radtke KL
ChemMedChem; 2018 Jan; 13(2):178-185. PubMed ID: 29193845
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Wang L; Liu X; Duan Y; Li X; Zhao B; Wang C; Xiao Z; Zheng P; Tang Q; Zhu W
Chem Biol Drug Des; 2018 Jul; 92(1):1301-1314. PubMed ID: 29575727
[TBL] [Abstract][Full Text] [Related]
8. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L
Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.
Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM
Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antiproliferative activity of C5-benzyl substituted 2-amino-pyrrolo[2,3-d]pyrimidines as potent Hsp90 inhibitors.
Lee JH; Shin SC; Seo SH; Seo YH; Jeong N; Kim CW; Kim EE; Keum G
Bioorg Med Chem Lett; 2017 Jan; 27(2):237-241. PubMed ID: 27914802
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.
Temburnikar KW; Zimmermann SC; Kim NT; Ross CR; Gelbmann C; Salomon CE; Wilson GM; Balzarini J; Seley-Radtke KL
Bioorg Med Chem; 2014 Apr; 22(7):2113-22. PubMed ID: 24631358
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel 7
Liu YM; Chen CH; Yeh TK; Liou JP
Future Med Chem; 2019 May; 11(9):959-974. PubMed ID: 30789758
[No Abstract] [Full Text] [Related]
14. Novel water-soluble substituted pyrrolo[3,2-d]pyrimidines: design, synthesis, and biological evaluation as antitubulin antitumor agents.
Gangjee A; Pavana RK; Li W; Hamel E; Westbrook C; Mooberry SL
Pharm Res; 2012 Nov; 29(11):3033-9. PubMed ID: 22814902
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
Liu Y; Zhang C; Zhang H; Li M; Yuan J; Zhang Y; Zhou J; Guo H; Zhao L; Du Y; Wang L; Ren L
Eur J Med Chem; 2015 Mar; 93():142-55. PubMed ID: 25668494
[TBL] [Abstract][Full Text] [Related]
16. Targeting dihydrofolate reductase: Design, synthesis and biological evaluation of novel 6-substituted pyrrolo[2,3-d]pyrimidines as nonclassical antifolates and as potential antitumor agents.
Gao T; Zhang C; Shi X; Guo R; Zhang K; Gu J; Li L; Li S; Zheng Q; Cui M; Cui M; Gao X; Liu Y; Wang L
Eur J Med Chem; 2019 Sep; 178():329-340. PubMed ID: 31200235
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of novel pyrrolo[2,3-d]pyrimidin-4-ones.
Atapour-Mashhad H; Tayarani-Najaran Z; Davoodnia A; Moloudi R; Mousavi SH
Drug Chem Toxicol; 2011 Jul; 34(3):271-6. PubMed ID: 21649481
[TBL] [Abstract][Full Text] [Related]
18. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of pyrazolo[1,5-a]pyrimidine linked aminobenzothiazole conjugates as potential anticancer agents.
Kamal A; Tamboli JR; Nayak VL; Adil SF; Vishnuvardhan MV; Ramakrishna S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3208-15. PubMed ID: 23623491
[TBL] [Abstract][Full Text] [Related]
20. Structural and Biological Investigations for a Series of N-5 Substituted Pyrrolo[3,2-
Cawrse BM; Robinson NM; Lee NC; Wilson GM; Seley-Radtke KL
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
